Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alteplase versus aspirin for acute ischemic stroke
PACTR201905578860441Phase 4Recruiting
- Sponsor
- Faculty of medicine
- Start
- Jan 2018
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of tissue-plasminogen activator and aspirin in ischemic stroke (2 arms), sponsored by Faculty of medicine. Primary endpoint: Early neurological improvement at 24 hours. Started Jan 2018; status: recruiting.
02
Drugs
tissue-plasminogen activatoraspirin
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on PACTR201905578860441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201905578860441.